Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Chronic Subdural Hematomas
NCT06718751Phase 2Not yet recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tranexamic acid in chronic subdural hematoma (CSDH), sponsored by Baylor College of Medicine. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT06718751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06718751.